Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer

[1]  G. Wahl,et al.  Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development , 2018, Cell reports.

[2]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[3]  E. Kass,et al.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer. , 2018, Annual review of cancer biology.

[4]  Hans Clevers,et al.  A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity , 2018, Cell.

[5]  Hans Clevers,et al.  BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance , 2017, Nature Methods.

[6]  R. Bronson,et al.  Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours , 2017, Nature Communications.

[7]  Mairian Thomas,et al.  Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids , 2016, Nature Communications.

[8]  A. Giobbie-Hurder,et al.  BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells. , 2016, Molecular cell.

[9]  J. Visvader,et al.  Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. , 2016, Cell stem cell.

[10]  W. Tarn,et al.  RBM4 promotes neuronal differentiation and neurite outgrowth by modulating Numb isoform expression , 2016, Molecular biology of the cell.

[11]  Hans Clevers,et al.  Organoid culture systems for prostate epithelial tissue and prostate cancer tissue , 2016, Nature Protocols.

[12]  D. Durocher,et al.  A mechanism for the suppression of homologous recombination in G1 cells , 2015, Nature.

[13]  P. P. Di Fiore,et al.  The Numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells , 2015, The Journal of cell biology.

[14]  B. Győrffy,et al.  BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters? , 2015, Pathobiology.

[15]  H. Nakshatri,et al.  Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization , 2015, Scientific Reports.

[16]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[17]  T. Blundell,et al.  Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif , 2015, Progress in biophysics and molecular biology.

[18]  Martin Kircher,et al.  Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. , 2015, Cancer discovery.

[19]  A. Meunier,et al.  NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer , 2014, Nature Reviews Urology.

[20]  J. Visvader,et al.  Mammary stem cells and the differentiation hierarchy: current status and perspectives , 2014, Genes & development.

[21]  H. Kurumizaka,et al.  FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair. , 2014, Cell reports.

[22]  O. Murina,et al.  FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. , 2014, Cell reports.

[23]  Zhe Li,et al.  Lineage Tracing of Mammary Epithelial Cells Using Cell-Type-Specific Cre-Expressing Adenoviruses , 2014, Stem cell reports.

[24]  D. Friedmann-Morvinski,et al.  Dedifferentiation and reprogramming: origins of cancer stem cells , 2014, EMBO reports.

[25]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[26]  Jason I. Herschkowitz,et al.  Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts , 2013, Genome Biology.

[27]  H. Clevers,et al.  Generation of BAC Transgenic Epithelial Organoids , 2013, PloS one.

[28]  J. Blayney,et al.  BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers , 2013, Nucleic acids research.

[29]  Piotr J. Balwierz,et al.  Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. , 2013, Cancer cell.

[30]  M. Galka,et al.  Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis. , 2013, Molecular cell.

[31]  W. Zipfel,et al.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. , 2013, Cell stem cell.

[32]  Adam P. Rosebrock,et al.  A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. , 2013, Molecular cell.

[33]  S. Kawamoto,et al.  Rbfox3-regulated alternative splicing of Numb promotes neuronal differentiation during development , 2013, The Journal of cell biology.

[34]  D. Amadori,et al.  Elf5 inhibits epithelial mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2/Slug , 2012, Nature Cell Biology.

[35]  D. Gerloff,et al.  BRCT domains: A little more than kin, and less than kind , 2012, FEBS letters.

[36]  D. Livingston,et al.  Mechanisms of BRCA1 tumor suppression. , 2012, Cancer discovery.

[37]  Mark D. Johnson,et al.  Numb Regulates Glioma Stem Cell Fate and Growth by Altering Epidermal Growth Factor Receptor and Skp1‐Cullin‐F‐Box Ubiquitin Ligase Activity , 2012, Stem cells.

[38]  A. D’Andrea,et al.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. , 2012, Genes & development.

[39]  B. Neumann,et al.  53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress , 2011, Nature Cell Biology.

[40]  E. Lander,et al.  Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. , 2011, Cell stem cell.

[41]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[42]  A. Ashworth,et al.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.

[43]  Jeremy M. Stark,et al.  53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.

[44]  Junjie Chen,et al.  BRCA1 and its toolbox for the maintenance of genome integrity , 2010, Nature Reviews Molecular Cell Biology.

[45]  Kornelia Polyak,et al.  Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer , 2010, Clinical Cancer Research.

[46]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[47]  Sridhar Ramaswamy,et al.  A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. , 2009, Genes & development.

[48]  G. Lévesque,et al.  HES1 is a novel interactor of the Fanconi anemia core complex. , 2008, Blood.

[49]  S. Merajver,et al.  BRCA1 regulates human mammary stem/progenitor cell fate , 2008, Proceedings of the National Academy of Sciences.

[50]  Junjie Chen,et al.  CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response , 2007, Nature Structural &Molecular Biology.

[51]  Steven P Gygi,et al.  Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response , 2007, Science.

[52]  A. Ashworth,et al.  A mouse model of basal‐like breast carcinoma with metaplastic elements , 2007, The Journal of pathology.

[53]  Junjie Chen,et al.  BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. , 2006, Genes & development.

[54]  F. Couch,et al.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.

[55]  H. Huber,et al.  A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes , 2006, Oncogene.

[56]  M. Grompe,et al.  Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. , 2005, Human molecular genetics.

[57]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[58]  N. Osheroff,et al.  Etoposide, topoisomerase II and cancer. , 2005, Current medicinal chemistry. Anti-cancer agents.

[59]  Junjie Chen,et al.  DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains , 2004, Molecular and Cellular Biology.

[60]  Michael B Yaffe,et al.  BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting , 2003, Science.

[61]  Georges Mer,et al.  The BRCT Domain Is a Phospho-Protein Binding Domain , 2003, Science.

[62]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[63]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[64]  Dho Se,et al.  Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain. , 1999 .

[65]  C. McGlade,et al.  Characterization of Four Mammalian Numb Protein Isoforms , 1999, The Journal of Biological Chemistry.

[66]  H. Lipshitz,et al.  Distinct human NUMB isoforms regulate differentiation vs. proliferation in the neuronal lineage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Thomas Ried,et al.  Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation , 1999, Nature Genetics.

[68]  F. Couch,et al.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. , 1998, Molecular cell.

[69]  Ralph Scully,et al.  Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.

[70]  Y. Jan,et al.  Control of Daughter Cell Fates during Asymmetric Division: Interaction of Numb and Notch , 1996, Neuron.

[71]  Y. Jan,et al.  numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos , 1989, Cell.

[72]  V. Ogryzko,et al.  Immunoaffinity purification of mammalian protein complexes. , 2003, Methods in enzymology.

[73]  Elgene Lim,et al.  Open Access Research Article Transcriptome Analyses of Mouse and Human Mammary Cell Subpopulations Reveal Multiple Conserved Genes and Pathways , 2022 .